newsfilter
← Latest News
GlobeNewswire·

ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment

More than 450 of the planned ~500 patients enrolled Interim superiority analysis expected around year-end 2020Call with KOL Dr. Manuel Hidalgo on September 29, 2020 at 10:00 am ET LYON, France and...